Induced pluripotent stem cells from a spinal muscular atrophy patient

Nature

Volumn 457, Issue 7227, 2009, Pages 277-280

  Ebert, Allison D ^a,b   Yu, Junying ^c   Rose Jr , Ferrill F ^d   Mattis, Virginia B ^d   Lorson, Christian L ^d   Thomson, James A ^b,c   Svendsen, Clive N ^a,b,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DRUG DEVELOPMENT; HERITABILITY; INFANT MORTALITY; MODELING; MUSCLE; NERVOUS SYSTEM DISORDER;

ARTICLE; CELL CULTURE; CHILD; CONTROLLED STUDY; DNA FINGERPRINTING; HUMAN; HUMAN CELL; MOTONEURON; NERVE CELL DIFFERENTIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN FIBROBLAST; SPINAL MUSCULAR ATROPHY;

CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; CHILD; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MALE; MODELS, BIOLOGICAL; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; SKIN; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 58249110796     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07677     Document Type: Article

References (41)

1. Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165 (1995).
2. Coovert, D. D. et al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205-1214 (1997).
3. Crawford, T. O. & Pardo, C. A. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3, 97-110 (1996).
4. Munsat, T. L. & Davies, K. E. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul. Disord. 2, 423-428 (1992).
5. Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307-6311 (1999).
6. Lefebvre, S. et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genet. 16, 265-269 (1997).
7. Schmid, A. & DiDonato, C. J. Animal models of spinal muscular atrophy. J. Child Neurol. 22, 1004-1012 (2007).
8. Schrank, B. et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA 94, 9920-9925 (1997).
9. DiDonato, C. J. et al. Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res. 7, 339-352 (1997).
10. Hsieh-Li, H. M. et al. A mouse model for spinal muscular atrophy. Nature Genet. 24, 66-70 (2000).
11. -/- mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333-339 (2000).
12. Le, T. T. et al. SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14, 845-857 (2005).
13. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
14. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008).
15. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
16. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
17. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883-2888 (2008).
18. Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221 (2008).
19. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
20. Jakel, R. J., Schneider, B. L. & Svendsen, C. N. Using human neural stem cells to model neurological disease. Nature Rev. Genet. 5, 136-144 (2004).
21. Gavrilov, D. K., Shi, X. Y., Das, K., Gilliam, T. C. & Wang, C. H. Differential SMN2 expression associated with SMA severity. Nature Genet. 20, 230-231 (1998).
22. Sumner, C. J. et al. SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials. Neurology 66, 1067-1073 (2006).
23. Fox, V. et al. Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation. Stem Cells 26, 715-723 (2008).
24. Svendsen, C. N. et al. A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods 85, 141-152 (1998).
25. Lendahl, U., Zimmerman, L. B. & McKay, R. D. G. Cns stem-cells express a new class of intermediate filament protein. Cell 60, 585-595 (1990).
26. Li, X. J. et al. Specification of motoneurons from human embryonic stem cells. Nature Biotechnol. 23, 215-221 (2005).
27. Jessell, T. M. Neuronal specification in the spinal cord: Inductive signals and transcriptional codes. Nature Rev. Genet. 1, 20-29 (2000).
28. Wichterle, H., Lieberam, I., Porter, J. A. & Jessell, T. M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397 (2002).
29. Carriedo, S. G., Yin, H. Z. & Weiss, J. H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16, 4069-4079 (1996).
30. Monani, U. R. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48, 885-896 (2005).
31. Brichta, L. et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum. Mol. Genet. 12, 2481-2489 (2003).
32. Sumner, C. J. et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann. Neurol. 54, 647-654 (2003).
33. Wolstencroft, E. C., Mattis, V., Bajer, A. A., Young, P. J. & Lorson, C. L. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum. Mol. Genet. 14, 1199-1210 (2005).
34. Pellizzoni, L., Yong, J. & Dreyfuss, G. Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775-1779 (2002).
35. Fischer, U., Liu, Q. & Dreyfuss, G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023-1029 (1997).
36. Liu, Q., Fischer, U., Wang, F. & Dreyfuss, G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90, 1013-1021 (1997).
37. Carrel, T. L. et al. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26, 11014-11022 (2006).
38. Zhang, H. et al. Multiprotein complexes of the survival of motor neuron protein SMN with gemins traffic to neuronal processes and growth cones of motor neurons. J. Neurosci. 26, 8622-8632 (2006).
39. Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003).
40. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003).
41. Suzuki, R. & Shimodaira, H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540-1542 (2006).